Cargando…
In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
Type 2 diabetes (T2D) is a rising global health problem mainly caused by obesity and a sedentary lifestyle. In healthy individuals, white adipose tissue (WAT) has a relevant homeostatic role in glucose metabolism, energy storage, and endocrine signaling. Mast cells contribute to these functions prom...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177010/ https://www.ncbi.nlm.nih.gov/pubmed/34093556 http://dx.doi.org/10.3389/fimmu.2021.664576 |
_version_ | 1783703340832522240 |
---|---|
author | Lopez-Perez, David Redruello-Romero, Anaïs Garcia-Rubio, Jesús Arana, Carlos Garcia-Escudero, Luis A. Tamayo, Francisco Puentes-Pardo, Jose D. Moreno-SanJuan, Sara Salmeron, Javier Blanco, Armando Galvez, Julio Leon, Josefa Carazo, Ángel |
author_facet | Lopez-Perez, David Redruello-Romero, Anaïs Garcia-Rubio, Jesús Arana, Carlos Garcia-Escudero, Luis A. Tamayo, Francisco Puentes-Pardo, Jose D. Moreno-SanJuan, Sara Salmeron, Javier Blanco, Armando Galvez, Julio Leon, Josefa Carazo, Ángel |
author_sort | Lopez-Perez, David |
collection | PubMed |
description | Type 2 diabetes (T2D) is a rising global health problem mainly caused by obesity and a sedentary lifestyle. In healthy individuals, white adipose tissue (WAT) has a relevant homeostatic role in glucose metabolism, energy storage, and endocrine signaling. Mast cells contribute to these functions promoting WAT angiogenesis and adipogenesis. In patients with T2D, inflammation dramatically impacts WAT functioning, which results in the recruitment of several leukocytes, including monocytes, that enhance this inflammation. Accordingly, the macrophages population rises as the WAT inflammation increases during the T2D status worsening. Since mast cell progenitors cannot arrive at WAT, the amount of WAT mast cells depends on how the new microenvironment affects progenitor and differentiated mast cells. Here, we employed a flow cytometry-based approach to analyze the number of mast cells from omental white adipose tissue (o-WAT) and subcutaneous white adipose tissue (s-WAT) in a cohort of 100 patients with obesity. Additionally, we measured the number of mast cell progenitors in a subcohort of 15 patients. The cohort was divided in three groups: non-T2D, pre-T2D, and T2D. Importantly, patients with T2D have a mild condition (HbA1c <7%). The number of mast cells and mast cell progenitors was lower in patients with T2D in both o-WAT and s-WAT in comparison to subjects from the pre-T2D and non-T2D groups. In the case of mast cells in o-WAT, there were statistically significant differences between non-T2D and T2D groups (p = 0.0031), together with pre-T2D and T2D groups (p=0.0097). However, in s-WAT, the differences are only between non-T2D and T2D groups (p=0.047). These differences have been obtained with patients with a mild T2D condition. Therefore, little changes in T2D status have a huge impact on the number of mast cells in WAT, especially in o-WAT. Due to the importance of mast cells in WAT physiology, their decrease can reduce the capacity of WAT, especially o-WAT, to store lipids and cause hypoxic cell deaths that will trigger inflammation. |
format | Online Article Text |
id | pubmed-8177010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81770102021-06-05 In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes Lopez-Perez, David Redruello-Romero, Anaïs Garcia-Rubio, Jesús Arana, Carlos Garcia-Escudero, Luis A. Tamayo, Francisco Puentes-Pardo, Jose D. Moreno-SanJuan, Sara Salmeron, Javier Blanco, Armando Galvez, Julio Leon, Josefa Carazo, Ángel Front Immunol Immunology Type 2 diabetes (T2D) is a rising global health problem mainly caused by obesity and a sedentary lifestyle. In healthy individuals, white adipose tissue (WAT) has a relevant homeostatic role in glucose metabolism, energy storage, and endocrine signaling. Mast cells contribute to these functions promoting WAT angiogenesis and adipogenesis. In patients with T2D, inflammation dramatically impacts WAT functioning, which results in the recruitment of several leukocytes, including monocytes, that enhance this inflammation. Accordingly, the macrophages population rises as the WAT inflammation increases during the T2D status worsening. Since mast cell progenitors cannot arrive at WAT, the amount of WAT mast cells depends on how the new microenvironment affects progenitor and differentiated mast cells. Here, we employed a flow cytometry-based approach to analyze the number of mast cells from omental white adipose tissue (o-WAT) and subcutaneous white adipose tissue (s-WAT) in a cohort of 100 patients with obesity. Additionally, we measured the number of mast cell progenitors in a subcohort of 15 patients. The cohort was divided in three groups: non-T2D, pre-T2D, and T2D. Importantly, patients with T2D have a mild condition (HbA1c <7%). The number of mast cells and mast cell progenitors was lower in patients with T2D in both o-WAT and s-WAT in comparison to subjects from the pre-T2D and non-T2D groups. In the case of mast cells in o-WAT, there were statistically significant differences between non-T2D and T2D groups (p = 0.0031), together with pre-T2D and T2D groups (p=0.0097). However, in s-WAT, the differences are only between non-T2D and T2D groups (p=0.047). These differences have been obtained with patients with a mild T2D condition. Therefore, little changes in T2D status have a huge impact on the number of mast cells in WAT, especially in o-WAT. Due to the importance of mast cells in WAT physiology, their decrease can reduce the capacity of WAT, especially o-WAT, to store lipids and cause hypoxic cell deaths that will trigger inflammation. Frontiers Media S.A. 2021-05-21 /pmc/articles/PMC8177010/ /pubmed/34093556 http://dx.doi.org/10.3389/fimmu.2021.664576 Text en Copyright © 2021 Lopez-Perez, Redruello-Romero, Garcia-Rubio, Arana, Garcia-Escudero, Tamayo, Puentes-Pardo, Moreno-SanJuan, Salmeron, Blanco, Galvez, Leon and Carazo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Lopez-Perez, David Redruello-Romero, Anaïs Garcia-Rubio, Jesús Arana, Carlos Garcia-Escudero, Luis A. Tamayo, Francisco Puentes-Pardo, Jose D. Moreno-SanJuan, Sara Salmeron, Javier Blanco, Armando Galvez, Julio Leon, Josefa Carazo, Ángel In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes |
title | In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes |
title_full | In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes |
title_fullStr | In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes |
title_full_unstemmed | In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes |
title_short | In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes |
title_sort | in patients with obesity, the number of adipose tissue mast cells is significantly lower in subjects with type 2 diabetes |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177010/ https://www.ncbi.nlm.nih.gov/pubmed/34093556 http://dx.doi.org/10.3389/fimmu.2021.664576 |
work_keys_str_mv | AT lopezperezdavid inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT redruelloromeroanais inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT garciarubiojesus inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT aranacarlos inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT garciaescuderoluisa inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT tamayofrancisco inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT puentespardojosed inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT morenosanjuansara inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT salmeronjavier inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT blancoarmando inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT galvezjulio inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT leonjosefa inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes AT carazoangel inpatientswithobesitythenumberofadiposetissuemastcellsissignificantlylowerinsubjectswithtype2diabetes |